Public Safety Concerns Support FDA Call for Compounding Pharmacy Regulation

Posted 23 September 2013 By Rachel A. Hardy, MA, RAC

Both the US Food and Drug Administration (FDA) and state authorities play a role in regulating compounding pharmacies. However, because the lines of authority are poorly delineated, facility oversight is inadequate. To increase public trust in the drug supply, new regulatory solutions must be considered.

Share this article:

Categories: Features, US, FDA

Tags: Pharmaceutical Compounding, NECC, Meningitis, Compounding

Regulatory Exchange: Latest Updates From the Community